TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment.
Saved in:
| Title: | TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment. |
|---|---|
| Authors: | Azar F; Transgene SA, Illkirch-Graffenstaden, France., Deforges J; Transgene SA, Illkirch-Graffenstaden, France., Demeusoit C; Transgene SA, Illkirch-Graffenstaden, France., Kleinpeter P; Transgene SA, Illkirch-Graffenstaden, France., Remy C; Transgene SA, Illkirch-Graffenstaden, France., Silvestre N; Transgene SA, Illkirch-Graffenstaden, France., Foloppe J; Transgene SA, Illkirch-Graffenstaden, France., Fend L; Transgene SA, Illkirch-Graffenstaden, France., Spring-Giusti C; Transgene SA, Illkirch-Graffenstaden, France., Quéméneur E; Transgene SA, Illkirch-Graffenstaden, France., Marchand JB; Transgene SA, Illkirch-Graffenstaden, France jem@transgene.fr. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jul 25; Vol. 12 (7). Date of Electronic Publication: 2024 Jul 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2051-1426 |
|---|---|
| DOI: | 10.1136/jitc-2024-009302 |
